-
In the Pipeline
-
Almotriptan malate (Axert) a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, otherwise known as a triptan, was approved by the U.S. Food and Drug Administration (FDA) in May 2001.
-
In other legislation favorable to pharmacists, the Senate Committee on Health, Education, Labor, and Pensions recently passed a bipartisan bill that would provide two student loan repayment programs for certain pharmacists. The bill now moves on to the Senate floor for consideration.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
As hospital systems add new technology to improve and change pharmacy department workflow, medication management also evolves and changes. This requires pharmacy leaders to anticipate new safety concerns and develop new practice models.
-
Hospital pharmacies nationwide have five years remaining to collectively meet the 2015 initiative goals of the American Society of Health-System Pharmacists (ASHP) of Bethesda, MD, and so far there are mixed results.
-
The 2009 American Society of Health-System Pharmacists (ASHP) National Survey highlights the escalating trend of hospital pharmacists becoming more involved in clinical care.
-
The American Society of Health-System Pharmacists (ASHP) of Bethesda, MD, and the Institute for Safe Medication Practices (ISMP) of Horsham, PA, launched in mid-December, 2009, a new national alert system to prevent medication errors. It' called the National Alert Network for Serious Medication Errors (NAN).
-
Research shows that 60% to 80% of intensive care unit (ICU) patients experience delirium, making this a significant diagnosis in this population.
-
Expense-based budgeting is traditional; it's comfortable, and it's no longer top of the evolving hospital pharmacy's radar screen.